vs
CrossAmerica Partners LP（CAPL）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是CrossAmerica Partners LP的1.6倍（$1.4B vs $866.3M），瑞思迈净利率更高（27.6% vs 1.2%，领先26.4%），瑞思迈同比增速更快（11.0% vs -8.3%），瑞思迈自由现金流更多（$311.2M vs $22.4M），过去两年瑞思迈的营收复合增速更高（9.0% vs -4.1%）
塔峰资本合伙人（TowerBrook Capital Partners）是一家总部位于伦敦和纽约的投资管理公司，2005年从索罗斯基金管理分拆独立。该机构主打私募股权及结构性机会投资，曾收购奢侈品品牌Jimmy Choo控股权，截至2025年其管理规模超250亿美元，官网公示在管投资项目共110个。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CAPL vs RMD — 直观对比
营收规模更大
RMD
是对方的1.6倍
$866.3M
营收增速更快
RMD
高出19.2%
-8.3%
净利率更高
RMD
高出26.4%
1.2%
自由现金流更多
RMD
多$288.8M
$22.4M
两年增速更快
RMD
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $866.3M | $1.4B |
| 净利润 | $10.2M | $392.6M |
| 毛利率 | 12.4% | 61.8% |
| 营业利润率 | 3.0% | 34.6% |
| 净利率 | 1.2% | 27.6% |
| 营收同比 | -8.3% | 11.0% |
| 净利润同比 | -39.6% | 13.9% |
| 每股收益（稀释后） | $0.24 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPLRMD
| Q4 25 | $866.3M | $1.4B | ||
| Q3 25 | $971.8M | $1.3B | ||
| Q2 25 | $961.9M | $1.3B | ||
| Q1 25 | $862.5M | $1.3B | ||
| Q4 24 | $944.2M | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $941.5M | $1.2B |
净利润CAPLRMD
| Q4 25 | $10.2M | $392.6M | ||
| Q3 25 | $13.6M | $348.5M | ||
| Q2 25 | $25.2M | $379.7M | ||
| Q1 25 | $-7.1M | $365.0M | ||
| Q4 24 | $16.9M | $344.6M | ||
| Q3 24 | $10.7M | $311.4M | ||
| Q2 24 | $12.4M | $292.2M | ||
| Q1 24 | $-17.5M | $300.5M |
毛利率CAPLRMD
| Q4 25 | 12.4% | 61.8% | ||
| Q3 25 | 10.8% | 61.5% | ||
| Q2 25 | 10.5% | 60.8% | ||
| Q1 25 | 10.4% | 59.3% | ||
| Q4 24 | 10.7% | 58.6% | ||
| Q3 24 | 10.3% | 58.6% | ||
| Q2 24 | 9.2% | 58.5% | ||
| Q1 24 | 8.6% | 57.9% |
营业利润率CAPLRMD
| Q4 25 | 3.0% | 34.6% | ||
| Q3 25 | 2.9% | 33.4% | ||
| Q2 25 | 4.3% | 33.7% | ||
| Q1 25 | 0.2% | 33.0% | ||
| Q4 24 | 3.0% | 32.5% | ||
| Q3 24 | 2.5% | 31.6% | ||
| Q2 24 | 2.5% | 31.2% | ||
| Q1 24 | -1.4% | 31.3% |
净利率CAPLRMD
| Q4 25 | 1.2% | 27.6% | ||
| Q3 25 | 1.4% | 26.1% | ||
| Q2 25 | 2.6% | 28.2% | ||
| Q1 25 | -0.8% | 28.3% | ||
| Q4 24 | 1.8% | 26.9% | ||
| Q3 24 | 1.0% | 25.4% | ||
| Q2 24 | 1.1% | 23.9% | ||
| Q1 24 | -1.9% | 25.1% |
每股收益（稀释后）CAPLRMD
| Q4 25 | $0.24 | $2.68 | ||
| Q3 25 | $0.34 | $2.37 | ||
| Q2 25 | $0.64 | $2.58 | ||
| Q1 25 | $-0.20 | $2.48 | ||
| Q4 24 | $0.42 | $2.34 | ||
| Q3 24 | $0.27 | $2.11 | ||
| Q2 24 | $0.31 | $1.97 | ||
| Q1 24 | $-0.48 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.1M | $1.4B |
| 总债务越低越好 | $687.2M | $403.9M |
| 股东权益账面价值 | — | $6.3B |
| 总资产 | $964.7M | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CAPLRMD
| Q4 25 | $3.1M | $1.4B | ||
| Q3 25 | $5.8M | $1.4B | ||
| Q2 25 | $9.7M | $1.2B | ||
| Q1 25 | $6.7M | $932.7M | ||
| Q4 24 | $3.4M | $521.9M | ||
| Q3 24 | $7.8M | $426.4M | ||
| Q2 24 | $5.5M | $238.4M | ||
| Q1 24 | $6.3M | $237.9M |
总债务CAPLRMD
| Q4 25 | $687.2M | $403.9M | ||
| Q3 25 | $700.8M | $408.7M | ||
| Q2 25 | $722.7M | $658.4M | ||
| Q1 25 | $774.1M | $663.1M | ||
| Q4 24 | $763.9M | $662.9M | ||
| Q3 24 | $769.2M | $667.6M | ||
| Q2 24 | $786.7M | $697.3M | ||
| Q1 24 | $795.8M | $997.0M |
股东权益CAPLRMD
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产CAPLRMD
| Q4 25 | $964.7M | $8.5B | ||
| Q3 25 | $998.9M | $8.3B | ||
| Q2 25 | $1.0B | $8.2B | ||
| Q1 25 | $1.1B | $7.6B | ||
| Q4 24 | $1.1B | $7.1B | ||
| Q3 24 | $1.1B | $7.2B | ||
| Q2 24 | $1.2B | $6.9B | ||
| Q1 24 | $1.2B | $6.8B |
负债/权益比CAPLRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $22.4M | $311.2M |
| 自由现金流率自由现金流/营收 | 2.6% | 21.9% |
| 资本支出强度资本支出/营收 | 0.8% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.89× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $55.8M | $1.8B |
8季度趋势，按日历期对齐
经营现金流CAPLRMD
| Q4 25 | $29.4M | $339.7M | ||
| Q3 25 | $24.4M | $457.3M | ||
| Q2 25 | $22.6M | $538.8M | ||
| Q1 25 | $15.0M | $578.7M | ||
| Q4 24 | $11.1M | $308.6M | ||
| Q3 24 | $41.9M | $325.5M | ||
| Q2 24 | $28.9M | $440.1M | ||
| Q1 24 | $5.8M | $402.0M |
自由现金流CAPLRMD
| Q4 25 | $22.4M | $311.2M | ||
| Q3 25 | $17.7M | $414.4M | ||
| Q2 25 | $10.8M | $508.2M | ||
| Q1 25 | $4.9M | $557.9M | ||
| Q4 24 | $3.9M | $288.0M | ||
| Q3 24 | $34.2M | $307.7M | ||
| Q2 24 | $23.6M | $415.2M | ||
| Q1 24 | $-289.0K | $380.8M |
自由现金流率CAPLRMD
| Q4 25 | 2.6% | 21.9% | ||
| Q3 25 | 1.8% | 31.0% | ||
| Q2 25 | 1.1% | 37.7% | ||
| Q1 25 | 0.6% | 43.2% | ||
| Q4 24 | 0.4% | 22.5% | ||
| Q3 24 | 3.2% | 25.1% | ||
| Q2 24 | 2.1% | 33.9% | ||
| Q1 24 | -0.0% | 31.8% |
资本支出强度CAPLRMD
| Q4 25 | 0.8% | 2.0% | ||
| Q3 25 | 0.7% | 3.2% | ||
| Q2 25 | 1.2% | 2.3% | ||
| Q1 25 | 1.2% | 1.6% | ||
| Q4 24 | 0.8% | 1.6% | ||
| Q3 24 | 0.7% | 1.5% | ||
| Q2 24 | 0.5% | 2.0% | ||
| Q1 24 | 0.6% | 1.8% |
现金转化率CAPLRMD
| Q4 25 | 2.89× | 0.87× | ||
| Q3 25 | 1.79× | 1.31× | ||
| Q2 25 | 0.90× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | 0.66× | 0.90× | ||
| Q3 24 | 3.92× | 1.05× | ||
| Q2 24 | 2.33× | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPL
| Retail Segment | $505.3M | 58% |
| Wholesale | $360.9M | 42% |
| Other | $1.2M | 0% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
